Join the club for FREE to access the whole archive and other member benefits.

Aubrey de Grey shortens timeframe for human rejuvenation

Once proven in mice, demand and funding will surge

28-Feb-2019

Key points from article :

Aubrey de Grey is getting more bullish about his timeframes for robust human rejuvenation.

He now thinks longevity escape velocity is only 18 years away and not 25 years anymore.

Rapid increase in funding and formation of companies.

Mitosens research now rapidly progressing.

Cross-linking is making progress as well

Robust mouse rejuvenation could be by 2022.

AgeX's Purestem creates highly pure populations of particular types of stem cells.

Also working on iTr induced tissue regeneration (or rejuvenation).

Mentioned in this article:

Click on resource name for more details.

AgeX Therapeutics

Biotechnology company focused on the development of novel therapeutics for age-related degenerative disease

Aubrey de Grey

President and Chief Science Officer at Longevity Escape Velocity (LEV) Foundation

Topics mentioned on this page:
Longevity Escape Velocity, SENS
Aubrey de Grey shortens timeframe for human rejuvenation